|
Model Number BB811 |
Device Problems
Crack (1135); Fluid/Blood Leak (1250); Air/Gas in Device (4062)
|
Patient Problem
Hemorrhage/Bleeding (1888)
|
Event Date 07/02/2022 |
Event Type
malfunction
|
Event Description
|
Medtronic received information that during use of a fusion oxygenator, the customer reported that the oxygenator had cracks and blood was running when the machine was on.The device was replaced to complete the procedure.There was no patient impact associated with this event.Medtronic received additional information that the amount of blood lost because of the issues was 200 ml and a transfusion was not required because of the device issue.There was blood leaking from the cracks.The customer stated that there was no leak from the base of the oxygenator and that there was no damage to the packaging or other contents within the package.The customer observed that there was air in the system/tubing.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Correction d4: expiration date, lot #, and udi added.Correction h4: manufactured date added.Conclusion: complaint confirmed for a fiber bundle leak.The device was not returned; however, a video/pictures from the customer show a fiber leak.This type of leak rarely occurs because the fusion hfo is 100 % leak tested during production and any leaks identified during testing are discarded.The detection of leaks prior to the distribution of the device has helped keep the occurrence rate of fiber leaks in the affinity fusion oxygenator at an acceptable rate.Fiber bundle leaks occasionally occur in oxygenators made with microporous membrane due to the variability in the fiber.The images also show blood dripping down into the bottom of the device and wicking between components.No cracks can be seen from the pictures.Trends for issues with this product are reviewed at quarterly quality meetings.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|